Anti‑angiogenic effect of Bryopsis plumosa ‑derived peptide via aquaporin 3 in non‑small cell lung cancer
International Journal of Oncology · 2024
DOI: 10.3892/ijo.2024.5711 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Oncology, 2024. Verfasst von Heabin Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bio‑material Research, National Marine Biodiversity Institute of Korea, Seocheon 33662, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Aquaporin 3, Zebrafish, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Developing novel anti‑angiogenic agents with minimal toxicity is notably challenging for cancer therapeutics. The discovery and development of peptides, whether derived from natural sources or synthesized, has potential for developing anti‑angiogenic agents characterized by their ability to penetrate cancer cells, high specificity and low toxicity. The present study identified a Bryopsis plumose‑derived anticancer and anti‑angiogenesis marine‑derived peptide 06 (MP06). A 22‑amino acid peptide was synthesized and conjugated with fluorescein isothiocyanate (FITC‑MP06) for intracellular localization in H1299 non‑small cell lung cancer cells. Regulatory effects of this peptide on the viability, migration and self‑renewal of lung cancer cells was assessed. Furthermore, anti‑angiogenic effect of MP06 was investigated by monitoring vascular tube formation in human umbilical vein endothelial cells and a zebrafish model. Aquaporin (AQP)3, a membrane channel in various tissues, is involved in regulating stemness, epithelial‑mesenchymal transition (EMT) and angiogenesis. MP06 downregulated AQP3 expression. Consistently, AQP3 knockdown by RNA silencing downregulated its gene expression, leading to a decrease in stemness, EMT and angiogenesis properties in H1299 cells. MP06 could thus serve as a novel therapeutic target with anticancer and angiogenesis properties for non‑small cell lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bio‑material Research, National Marine Biodiversity Institute of Korea, Seocheon 33662, Republic of Korea.
- Department of Biological Application & Technology, National Marine Biodiversity Institute of Korea, Seocheon 33662, Republic of Korea.
- Department of Ecology & Conservation, National Marine Biodiversity Institute of Korea, Seocheon 33662, Republic of Korea.
Zitieren
APA
Kim, H., Jung, S. H., Jo, S., Han, J. W., Yoon, M., & Lee, J. H. (2024). Anti‑angiogenic effect of Bryopsis plumosa ‑derived peptide via aquaporin 3 in non‑small cell lung cancer. International Journal of Oncology. https://doi.org/10.3892/ijo.2024.5711
Vancouver
Kim H, Jung SH, Jo S, Han JW, Yoon M, Lee JH. Anti‑angiogenic effect of Bryopsis plumosa ‑derived peptide via aquaporin 3 in non‑small cell lung cancer. International Journal of Oncology. 2024. doi:10.3892/ijo.2024.5711
BibTeX
@article{Kim2024,
author = {Kim, Heabin and Jung, Seung-Hyun and Jo, Seonmi and Han, Jong Won and Yoon, Moongeun and Lee, Jei Ha},
title = {Anti‑angiogenic effect of Bryopsis plumosa ‑derived peptide via aquaporin 3 in non‑small cell lung cancer},
journal = {International Journal of Oncology},
year = {2024},
doi = {10.3892/ijo.2024.5711}
}
EUVIMED